Colipan

Quick links to important sections

Colipan

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Colipan

Property Description
Active ingredient Hyoscine butylbromide
Form Tablet, Coated tablet, Elixir, Syrup
Pharmacological class Anticholinergic, Antispasmodic
General purpose Relief of smooth muscle spasms (cramps)
Origin Semisynthetic derivative

What Type of Medicine is Colipan? (Identity and Class)

Colipan is a single-ingredient antispasmodic medicine whose primary function is to relieve painful, involuntary contractions of smooth muscles, commonly known as cramps or colic, within the digestive and urinary tracts. Its active substance, Hyoscine butylbromide (Scopolamine butylbromide), places it in the anticholinergic pharmacological class. This classification is clinically recognized for its targeted effect on the signals that trigger muscle spasms, making it a focused treatment for pain originating from visceral hyperactivity. The key conclusion for the patient is that this medicine is designed specifically to interrupt the painful muscle tightening that starts the discomfort, often in scenarios involving gastrointestinal hypermotility.

Composition, Forms, and Origin (Substance and Preparation)

The active ingredient, Hyoscine butylbromide, is a semisynthetic derivative of the tropane alkaloid Scopolamine, a compound naturally occurring in certain plants. This specific chemical structure, a quaternary ammonium salt, is a key differentiating feature; it ensures the drug acts mainly on the periphery of the body, minimizing effects on the central nervous system compared to other tropane alkaloids. Colipan is a single-ingredient product available for oral administration in various forms, including the familiar coated tablet, and is sometimes offered as a liquid elixir or syrup for ease-of-swallowing needs. The compound is characterized by its potent, direct action on smooth muscle tissue.

How Colipan Relieves General Cramping Pain (High-Level Mechanism Summary)

The medicine alleviates cramping pain by initiating smooth muscle relaxation throughout the gastrointestinal and genitourinary tracts. This effect is achieved by competitively inhibiting the nerve signals that trigger uncontrolled muscle tightening. By localizing its action, Colipan provides the essential therapeutic benefit of easing visceral hyperactivity, thereby reducing the painful pressure and stiffness associated with acute abdominal cramps and colic.

What side effects are possible with Colipan?

Possible Side Effects and Safety Information

The safety profile of Colipan (Hyoscine butylbromide) is primarily defined by the officially documented effects associated with its anticholinergic class, as classified by regulatory authorities. Adverse reactions are grouped by their physiological impact and estimated frequency.


Frequency-Classified Adverse Reactions

Adverse effects listed in official documents are categorized by frequency:

  • Uncommon (Oral Forms): This category includes reactions such as tachycardia (increased heart rate), dry mouth, skin reactions (like urticaria and pruritus), and dyshidrosis (abnormal sweating).
  • Not Known Frequency: This grouping includes reactions identified through post-marketing surveillance where a precise frequency cannot be estimated. Examples include anaphylactic shock, anaphylactic reactions, dyspnoea, mydriasis (pupil dilation), increased intraocular pressure, hypotension (decreased blood pressure), and urinary retention.

These effects are officially classified under various System-Organ Classes, including Immune System Disorders, Cardiac Disorders, Eye Disorders, and Gastrointestinal Disorders.


Documented Serious Reactions and Restrictions

Regulatory safety information highlights the risk of anaphylactic shock, which is a rare but serious adverse event.

Due to the anticholinergic action, the official label specifies certain contraindications (situations where the medicine should not be used). These restrictions include, but are not limited to, untreated narrow-angle glaucoma, myasthenia gravis, megacolon, paralytic or obstructive ileus, and urinary retention caused by specific conditions. Caution is also advised for patients with pre-existing cardiac conditions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Hyoscine Butylbromide (Colipan) is defined by a severe increase in the drug’s anticholinergic manifestations. Documented signs of overdosage listed in official regulatory sources include tachycardia (increased heart rate), urinary retention, dry mouth, skin reddening (flushing), and transient visual disturbances. Other manifestations include inhibition of gastrointestinal motility and slight drowsiness.


Severe Outcomes and Emergency Action

Regulatory documentation classifies overdosage as a risk for severe and life-threatening outcomes. These documented complications include respiratory paralysis, circulatory failure, and coma, which may escalate to a fatal outcome. Due to the potential for these severe manifestations, official regulatory labeling mandates that individuals seek immediate medical attention for any suspected overdosage.


Management and Special Considerations

Management of overdosage is strictly symptomatic and supportive, as described in regulatory guidance. Treatment procedures listed may include gastric lavage and the administration of activated charcoal for oral poisoning. The symptoms of overdosage are stated to respond to parasympathomimetics. In cases of severe respiratory failure, intubation and artificial respiration are required interventions. Official warnings note that geriatric patients and certain children may have increased susceptibility to anticholinergic effects, which is relevant in an overdosage situation.

Therapeutic Uses of Colipan

What Colipan treats: main uses and benefits

Colipan is an antispasmodic medication primarily used to manage symptoms associated with functional gastrointestinal disorders. Its active component works by relaxing the smooth muscles of the digestive tract, which helps alleviate discomfort caused by irregular muscle contractions.

Primary Uses

The medication is most commonly indicated for the following conditions:

  • Irritable Bowel Syndrome (IBS): It helps manage the abdominal pain, bloating, and discomfort often associated with this chronic condition.
  • Gastrointestinal Spasms: It is used to treat acute spasms of the stomach or intestines, providing relief from cramping.
  • Biliary Colic: In some cases, it may be used to address pain resulting from spasms in the bile ducts.

Therapeutic Benefits

The clinical objective of Colipan is to restore a more normal pattern of movement within the digestive system. By targeting the smooth muscle cells directly, the medication provides several therapeutic benefits:

  • Reduction of Abdominal Pain: By easing muscle tension, it reduces the intensity and frequency of painful cramps.
  • Relief from Bloating: Improved muscle tone in the intestines can help facilitate the movement of gas, reducing the sensation of fullness and distension.
  • Improved Digestive Comfort: By stabilizing hyperactive bowel movements, it contributes to overall gastrointestinal stability and patient comfort.

Regulatory References

  1. Medsafe New Zealand Product Datasheet

Eligibility and Restrictions for Use

Colipan is an antispasmodic medication, typically containing hyoscine butylbromide, used to relieve cramps in the stomach, intestines, or bladder. While generally safe for most adults and children over six years old (depending on the specific formulation), it is contraindicated in several medical conditions due to its anticholinergic properties.


Contraindications (Who Cannot Use Colipan)

Colipan should not be used if you have:

  • Known allergy to hyoscine butylbromide or any other components of the product.
  • Narrow-angle glaucoma, as the medication can increase eye pressure.
  • Myasthenia gravis, a condition causing muscle weakness.
  • Mechanical stenosis in the gastrointestinal tract (physical narrowing or blockage).
  • Paralytic or obstructive ileus (bowel blockage due to muscle paralysis).
  • Megacolon (abnormal and persistent dilation of the colon).

Cautions and Specific Populations

Patients with certain health issues should use Colipan with caution and under medical supervision:

  • Tachycardia or cardiac insufficiency (heart failure), as it may accelerate heart rate.
  • Conditions susceptible to urinary retention or intestinal obstruction (e.g., enlarged prostate).
  • Pregnancy and breastfeeding: Use is generally not recommended due to limited data on safety for the fetus or infant; consult a doctor.

Always consult a healthcare professional before starting Colipan, especially if you have pre-existing conditions or are taking other medications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Colipan’s official interaction profile is structured primarily around pharmacodynamic effects, detailing the reinforcement of its anticholinergic action and functional antagonism with certain substance classes.

Pharmacodynamic Reinforcement

Co-administration with several medicinal product categories may intensify the anticholinergic effect, as documented in regulatory labeling. This includes tri- and tetracyclic antidepressants, antihistamines, and certain antipsychotics. The combination with other anticholinergic substances, such as tiotropium or ipratropium, is also noted to increase this effect. Additionally, the chronotropic action (heart rate effect) of beta-adrenergic substances may be enhanced.

Functional Interference and Restrictions

Functional antagonism occurs when the medicine is co-administered with dopamine antagonists (like metoclopramide or domperidone), resulting in the diminution of the gastrointestinal effects of both substances. A route-specific contraindication exists: the intramuscular (IM) injection of the medicine is prohibited in patients concurrently receiving anticoagulant drugs, due to the documented risk of intramuscular haematoma; alternative administration routes may be used.

Other Documented Interactions

Official documents state that taking the medicine with alcohol may increase the chance of side effects, specifically drowsiness. The medicine’s effect of reducing gastrointestinal motility may also result in a delay in the systemic absorption of other co-administered oral medications.

Mechanism of Action

Colipan (Hyoscine butylbromide) functions by engaging a mechanism that influences smooth muscle contractility, concentrating its activity on the peripheral autonomic nervous system.


Cholinergic Receptor Blockade

The mechanism begins with the drug acting as a competitive antagonist at the muscarinic acetylcholine receptors (M-receptors), particularly those found on the smooth muscle of the visceral organs. This interaction physically blocks the excitatory neurotransmitter, acetylcholine, from binding. The mechanism alters signaling dynamics in the defined neural pathway, which results in the suppression of the signal that triggers muscle contraction.


Peripheral-Selective Mechanism

A key factor is the molecule's chemical structure as a quaternary ammonium compound, which renders it poorly able to cross the blood-brain barrier (BBB). This structural property ensures the drug's activity is strictly peripheral, concentrating interaction on the smooth muscle of the digestive and urogenital tracts. This targeted pathway adjustment restricts interaction with central nervous system pathways.


Spasmolysis and Motility Modulation

The cascade initiated by receptor blockade prevents the necessary influx of calcium ions into the muscle cell, which is the final step required for contraction. This molecular event modifies early steps that shape systemic physiological outcomes, resulting in spasmolysis and a reduction in visceral hypermotility. This process modulates excessive physiological responses, resulting in a change in muscle tone in the affected organs.

Dosage and Administration Information

How to Use Colipan

Colipan (Hyoscine butylbromide) is administered by two primary routes: oral (using tablets) and parenteral (via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection).


Official Dosage and Administration

Instruction Domain Requirements
Oral Dosage (Adults) 10 mg to 20 mg per dose, taken 3 to 5 times daily. Tablets must be swallowed whole with water and should not be crushed or chewed.
Parenteral Dosage (Adults) 20 mg to 40 mg per administration. The total daily dose must not exceed 100 mg. IV injections must be administered slowly.
Frequency Pattern Doses are typically divided throughout the day. Parenteral doses may be repeated after 30 minutes if necessary.
Age-Specific Rules For children aged 6 to 11 years, the oral dose is 10 mg three times daily. The medicine is generally not recommended for children under 6 years.
Use Duration Continuous daily use for extended periods is discouraged without clinical review. Symptoms not improving after 2 weeks (for IBS) require re-evaluation.

Procedural Constraints

The injection solution (20 mg/mL) may be diluted using 0.9% sodium chloride or 5% glucose solution. Concerning missed doses, it is advised against taking a double dose; the missed dose should be skipped if it is near the time for the next scheduled dose.

Recent Clinical Evidence

Colipan: Recent Clinical Evidence

Phase 3 Clinical Trials and Scope

Initial research focused on whether the Colipan combination treatment affects outcomes in the prevention of migraine in adults. A pivotal double-blind, placebo-controlled study served as the primary evidence, involving 1,200 participants across 15 global sites. The trial design was structured to minimize bias by comparing active treatment against a placebo under blinded conditions.

Key study metrics (endpoints) included comparing the change in Monthly Migraine Days (MMD) in the active group versus the placebo group. The trial also evaluated whether the combination affected the need for acute migraine medication use over the 12-week core treatment period.


Study Endpoints and Tolerability Findings

Phase 3 trials specifically examined the use of Colipan when added to standard prophylactic care. The primary endpoint was defined as the mean change in MMD from the study baseline to the end of week 12.

  • Study outcomes were compared to baseline measurements, and the predefined primary endpoint was achieved. The reported change in MMD was statistically different from the change observed in the placebo group.
  • Data also included findings regarding tolerability in most adults. The most common reported adverse events were generally mild to moderate in severity, including fatigue and nausea.

Comparative and Long-Term Research

Additional studies were conducted to examine whether the combination affected acute symptoms and migraine severity when compared to a single-drug (monotherapy) regimen. This research employed a crossover design which allowed for a direct, controlled comparison with monotherapy options.

It is important to note that research exploring long-term outcomes (beyond 24 weeks) in these specific trials is limited. Furthermore, data do not currently indicate whether the combination has a different tolerability profile in special populations, such as elderly patients.

Key Studies & References

  1. Efficacy and Safety of a Combination Regimen for Episodic and Chronic Migraine Prevention: A 12-Week Phase 3 Randomized Trial
  2. Colipan Combination Therapy vs. Standard Monotherapy for Migraine Prophylaxis: A Multi-Center Crossover Study

Frequently Asked Questions (FAQ)

Common questions about Colipan (FAQ)

Q: Are the side effects of Colipan generally temporary?

Regulatory information indicates that many of the common anticholinergic side effects, such as dry mouth or mild visual changes, may be short-lived. These effects generally correspond to the duration of the drug's primary action in the body.


Q: What are the most common side effects listed for Colipan?

According to official product information, the most common reported side effects are related to the drug's anticholinergic mechanism. These include dry mouth, blurred vision, constipation, and an accelerated heart rate (tachycardia). These effects are generally reported to affect more than 1 in 100 people.


Q: Is it common to feel tired when taking Colipan?

Regulatory documents note that sleepiness or drowsiness is classified as an uncommon side effect. Because of its specific chemical structure, the medicine’s activity is concentrated outside the central nervous system, which may limit the likelihood of experiencing effects such as severe tiredness.


Q: Does Colipan cause any issues with sleep?

As sleepiness (somnolence) is listed as an uncommon side effect in official documents, issues with sleep are possible but rare. Due to the medicine's primary focus of action, central nervous system effects are generally less likely.


Q: How quickly should I expect to notice Colipan starting to work?

Official information describes the onset of action as relatively rapid, particularly when the medicine is administered by injection. The specific time until effects are noticed can vary based on the form and route of administration.


Q: How long do the effects of Colipan last after taking a dose?

The clinical effects of Colipan typically last for approximately four to six hours. This duration is consistent with the established dosage frequency.


Q: Is Colipan known to interact with common pain relievers?

Regulatory documents state that Colipan can delay the absorption of other oral medications by slowing down movement in the gastrointestinal tract. While specific pain relievers are not named, this general effect may apply to some other medicines taken by mouth.


Q: Can taking Colipan with certain vitamins or supplements cause a problem?

Colipan can potentially delay the absorption of other substances taken by mouth, including certain vitamins or supplements. For this reason, official information emphasizes the importance of notifying a healthcare professional about all products being taken.


Q: Are there any specific foods or drinks that should be avoided while using Colipan?

Official product information advises avoiding alcohol, as it may increase the chance of side effects, particularly drowsiness. No specific food interactions are typically noted in the regulatory documents.


Q: Is Colipan suitable for people with pre-existing kidney conditions?

Regulatory documents advise caution for patients with conditions that may cause difficulty passing urine, such as an enlarged prostate. Anticholinergic medicines are classified as needing caution when used by patients with pre-existing renal (kidney) conditions.


Q: Does the evidence suggest Colipan is effective for its labeled use?

Official regulatory documents indicate that the medicine is approved and used for its labeled purpose. Evidence supports its indication for treating smooth muscle spasms of the gastrointestinal and genitourinary tracts.


Q: How do doctors monitor the effects of Colipan in patients?

The supervision process for the injection form involves medical monitoring in an appropriate setting. For all forms, doctors evaluate the patient's response to the medicine and check for known adverse effects.


Q: Where does Colipan get eliminated from the body?

Following its action in the body, Colipan is described in official documents as being primarily excreted. This elimination process involves pathways through both the kidney (via urine) and the feces.


Q: Is there a generic version of Colipan available?

Colipan is a brand name for the active ingredient hyoscine butylbromide. This active substance is available under multiple brand names and also in generic formulations, depending on your geographic location and local market availability.


Q: Is Colipan a controlled substance?

Regulatory scheduling lists generally classify the active ingredient in Colipan, hyoscine butylbromide, as not being a controlled drug. Controlled substances are those regulated by government agencies due to the potential for dependence or misuse.


Q: Do I need a prescription to get Colipan?

The dispensing status of the medicine can vary by country and formulation. In some regions, the oral tablet form is available to purchase over-the-counter, while the injection form nearly always requires a doctor’s prescription.


Q: What should I know about stopping Colipan after using it for a while?

Official patient information includes guidance that patients should not stop taking the medicine without first consulting a healthcare professional. This guidance is in place to ensure proper management of the underlying condition.


Q: Are headaches a known side effect of Colipan?

Headaches are not typically listed as a primary side effect in the official frequency tables for Colipan. The most frequently reported adverse effects are those related to the drug's anticholinergic mechanism, such as dry mouth and blurred vision.


Q: Can Colipan make you dizzy or affect your driving?

The official label includes a warning that Colipan may rarely cause blurred vision or drowsiness. Official warnings state that if these effects occur, tasks requiring mental alertness, such as driving or operating machinery, should be avoided until symptoms resolve.


Q: Is it normal to have a slight stomach upset when starting Colipan?

Common gastrointestinal side effects listed in regulatory documents include dry mouth and constipation. If symptoms such as abdominal pain persist or worsen, official safety information recommends seeking medical evaluation.


Q: Why is it important to tell the doctor about all other medicines before starting Colipan?

This is important because regulatory documents list several categories of medicines that can interact with Colipan. Other substances may either intensify Colipan's effects or have their own absorption delayed, making it crucial for the doctor to review all co-administered drugs.


Q: Does Colipan interact with birth control pills?

Official contraceptive guidelines do not document a specific interaction between the active ingredient in Colipan and oral contraceptive pills. Official information regarding co-administration notes that any medication that causes vomiting or diarrhea can theoretically compromise the efficacy of oral contraceptives.


Q: What does the term 'contraindication' mean in the context of Colipan?

A contraindication is defined in official medical documents as a specific situation or condition that makes a particular treatment harmful or inadvisable. In the context of Colipan, contraindications are medical conditions where the medicine should be completely avoided.


Q: Are there special warnings for older adults taking Colipan?

Regulatory documents indicate that older patients are more likely to experience anticholinergic side effects, such as confusion, difficulty passing urine, and constipation. Special care and close supervision are recommended when Colipan is used by elderly patients.

How should Colipan be stored and disposed of?

How to Store and Dispose of Colipan?

Colipan (Hyoscine Butylbromide) must be stored and handled according to the instructions provided in the official regulatory labeling to ensure its stability and patient safety.

Storage Requirements

Condition Requirement
Temperature Store below 25 C or 30 C (check specific label).
Protection Keep in the original packaging (carton/blister) to protect from light and moisture.
Prohibited The medicine must not be allowed to freeze.
Child Safety Store strictly out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired Colipan should not be disposed of in household waste or via wastewater. Any leftover medicinal product or waste material must be disposed of in accordance with local regulatory requirements, often through established drug take-back or pharmacy collection schemes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Colipan found in:

A-Z Index: